EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 …
…, N Sattar, DPM Symmons, MT Nurmohamed - Annals of the …, 2017 - ard.bmj.com
Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have
increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the …
increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the …
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
…, Z Szekanecz, N Sattar, MT Nurmohamed - Annals of the …, 2010 - ard.bmj.com
Objectives: To develop evidence-based EULAR recommendations for cardiovascular (CV)
risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and …
risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and …
[HTML][HTML] Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus
…, HG Raterman, MT Nurmohamed… - Mediators of …, 2010 - hindawi.com
Endothelial dysfunction is regarded as an important factor in the pathogenesis of vascular
disease in obesity-related type 2 diabetes. The imbalance in repair and injury (hyperglycemia, …
disease in obesity-related type 2 diabetes. The imbalance in repair and injury (hyperglycemia, …
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
MT Nurmohamed, HR Buller, E Dekker, DW Hommes… - The Lancet, 1992 - Elsevier
Low-molecular-weight heparins (LMWHs) have theoretical advantages over standard heparin
as postoperative thromboprophylactic agents. We conducted a meta-analysis of studies …
as postoperative thromboprophylactic agents. We conducted a meta-analysis of studies …
Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up
GM Bartelds, CLM Krieckaert, MT Nurmohamed… - Jama, 2011 - jamanetwork.com
… Dr Nurmohamed reports having received consultancy fees from Abbott, Roche, Pfizer, MSD,
UCB, BMS, and Wyeth; payment for lectures from Abbott, Roche, and Pfizer; and research …
UCB, BMS, and Wyeth; payment for lectures from Abbott, Roche, and Pfizer; and research …
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
…, CA Wijbrandts, MT Nurmohamed… - Annals of the …, 2007 - ard.bmj.com
Background: A substantial proportion of patients with rheumatoid arthritis (RA) do not respond,
or lose initial response, to adalimumab treatment. One explanation for non-response is …
or lose initial response, to adalimumab treatment. One explanation for non-response is …
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
…, E De Groot, MT Nurmohamed… - Arthritis & …, 2006 - Wiley Online Library
Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against
tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This …
tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This …
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation
…, BAC Dijkmans, MT Nurmohamed - Annals of the …, 2009 - ard.bmj.com
Objectives: Patients with rheumatoid arthritis (RA) have an increased cardiovascular risk, but
the magnitude of this risk is not known precisely. A study was undertaken to investigate the …
the magnitude of this risk is not known precisely. A study was undertaken to investigate the …
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
…, BAC Dijkmans, MT Nurmohamed - Arthritis Care & …, 2009 - Wiley Online Library
… Nurmohamed… Nurmohamed … Nurmohamed had full access to all of the data in the
study and takes responsibility for the integrity of the data and the accuracy of the data analysis. …
study and takes responsibility for the integrity of the data and the accuracy of the data analysis. …
Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis
…, BA Dijkmans, MT Nurmohamed - Seminars in arthritis and …, 2004 - Elsevier
OBJECTIVE: To evaluate the cardiovascular risk profile of spondylarthropathy patients,
particularly ankylosing spondylitis and psoriatic arthritis. METHODS: A Pubmed literature search …
particularly ankylosing spondylitis and psoriatic arthritis. METHODS: A Pubmed literature search …